Literature DB >> 10893436

Suppressive effect of the herbal medicine Oren-gedoku-to on cyclooxygenase-2 activity and azoxymethane-induced aberrant crypt foci development in rats.

M Fukutake1, N Miura, M Yamamoto, K Fukuda, O Iijima, H Ishikawa, M Kubo, M Okada, Y Komatsu, H Sasaki, K Wakabayashi, A Ishige, S Amagaya.   

Abstract

The present study is part of a program to obtain effective chemopreventive agents with low toxicity from medicinal herbs and traditional herbal medicines. We previously reported that Oren (Coptidis rhizoma) and Ogon (Scutellariae radix) inhibit azoxymethane (AOM)-induced aberrant crypt foci (ACF) formation. In the present investigation, we found Sanshishi (Gardeniae fructus) and the traditional herbal medicine Oren-gedoku-to (OGT), composed of Ogon, Oren, Sanshishi and Obaku, also have preventive potential. Sanshishi and OGT decreased the numbers of ACF to 25.2 and 59.4% of the control value at 2% in the diet, respectively. Adverse effects, evidenced by body weight loss, were weaker with OGT than component herbs. To investigate their mechanisms of action, the influence on cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) activities was studied. Both OGT and Sanshishi inhibited COX-2 but not COX-1, this presumably contributing to their suppressive effects on ACF development. The results suggest that OGT may be useful for colon cancer chemoprevention in terms of efficacy and toxicity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10893436     DOI: 10.1016/s0304-3835(00)00432-8

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

Review 1.  Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency.

Authors:  Denis E Corpet; Sylviane Taché
Journal:  Nutr Cancer       Date:  2002       Impact factor: 2.900

2.  Can licorice lick colon cancer?

Authors:  Paul M Stewart; Stephen M Prescott
Journal:  J Clin Invest       Date:  2009-04       Impact factor: 14.808

3.  The inhibitory effects of Orengedokuto on inducible PGE2 production in BV-2 microglial cells.

Authors:  Yoshika Iwata; Mariko Miyao; Akiko Hirotsu; Kenichiro Tatsumi; Tomonori Matsuyama; Nobuo Uetsuki; Tomoharu Tanaka
Journal:  Heliyon       Date:  2021-08-11

4.  Kampo Medicines for Mite Antigen-Induced Allergic Dermatitis in NC/Nga Mice.

Authors:  Xiu Kun Gao; Kazutoshi Fuseda; Tomonori Shibata; Hiroyuki Tanaka; Naoki Inagaki; Hiroichi Nagai
Journal:  Evid Based Complement Alternat Med       Date:  2005-03-23       Impact factor: 2.629

5.  Fever of unknown origin successfully treated by oren-gedoku-to (huanglian-jie-du-tang).

Authors:  Koichiro Tanaka; Kazuhiko Nara; Tetsuya Nishimura; Keiko Serizawa; Taito Miyazaki; Yoshihisa Urita; Oto Miura
Journal:  Int J Gen Med       Date:  2013-10-07

Review 6.  Anticancer activities and mechanisms of heat-clearing and detoxicating traditional Chinese herbal medicine.

Authors:  Yulin Zhang; Yeer Liang; Chengwei He
Journal:  Chin Med       Date:  2017-07-12       Impact factor: 5.455

Review 7.  Chinese medical herbs for chemotherapy side effects in colorectal cancer patients.

Authors:  W Taixiang; A J Munro; L Guanjian
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25

8.  Transcriptomics Analysis of Candida albicans Treated with Huanglian Jiedu Decoction Using RNA-seq.

Authors:  Qianqian Yang; Lei Gao; Maocan Tao; Zhe Chen; Xiaohong Yang; Yi Cao
Journal:  Evid Based Complement Alternat Med       Date:  2016-04-06       Impact factor: 2.629

Review 9.  Herbal bioactivation: the good, the bad and the ugly.

Authors:  Shufeng Zhou; Hwee-Ling Koh; Yihuai Gao; Zhi-yuan Gong; Edmund Jon Deoon Lee
Journal:  Life Sci       Date:  2004-01-09       Impact factor: 5.037

10.  Gardenia jasminoides Ellis Fruit Extracts Attenuated Colitis in 2,4,6-Trinitrobenzenesulfonic Acid-Induced Rats.

Authors:  Jing Liu; Chao Yang; Zhigui Wu; Jianguo Pei; Yao Chen; Xiao Huang; Sha Gao; Rui Kan; Wenna Zhang; Saisai Xie; Xiaomei Fu
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-15       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.